Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Phase Distribution

Ph not_applicable

75%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Detailed Status

Completed3

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (25.0%)

N/A3 (75.0%)

Trials by Status

completed375%

not_yet_recruiting125%

Recent Activity

0 active trials

Showing 4 of 4

not_yet_recruitingphase_2

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

NCT07333287

completednot_applicable

Clinical Trials (4)

Showing 4 of 4 trials

NCT07333287Phase 2

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Not Yet Recruiting

NCT05744180Not Applicable

A Study of Workflow-Integrated Artificial Intelligence for RPM Enrollment

Completed

NCT04785014Not Applicable

Effect of USG-guided Baker's Cyst Aspiration

Completed

NCT00323271Not Applicable

Cognitive-behavior Therapy for MS-Related Chronic Pain

Completed

All 4 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 4